Vaccinia Virus Vectors
- 1 January 1992
- book chapter
- Published by Elsevier in Biotechnology (reading, Mass.)
- Vol. 20, 345-362
- https://doi.org/10.1016/b978-0-7506-9265-6.50021-x
Abstract
No abstract availableThis publication has 151 references indexed in Scilit:
- An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.The Journal of Experimental Medicine, 1990
- Structure of vaccinia virus late promotersJournal of Molecular Biology, 1989
- Structure of vaccinia virus early promotersJournal of Molecular Biology, 1989
- Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cellsJournal of Molecular Biology, 1989
- A dominant selectable marker for the construction of recombinant poxvirusesGene, 1988
- Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infectionVirus Research, 1988
- Disseminated Vaccinia in a Military Recruit with Human Immunodeficiency Virus (HIV) DiseaseNew England Journal of Medicine, 1987
- Recognition of Influenza A Virus Nucleoprotein by Human Cytotoxic T LymphocytesJournal of General Virology, 1986
- Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.The Journal of Experimental Medicine, 1986
- Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNAGene, 1983